Gabbay Daniel
Known title: EVP, Chief Financial OfficerCIK: 0002113684
Gabbay Daniel's purchase track record
Gabbay Daniel has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/4/2026 | HR | $187 | +4.4% | +3.9% | +11.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HR | ▲ Buy | Open Market | 10 | $187 | 3/4/2026 | View on chart |
| HR | ▲ Buy | Grant | 32,107 | $550K | 2/9/2026 | View on chart |
| HR | ▲ Buy | Grant | 159,051 | $2.7M | 1/12/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
HR Faces Dividend Cut Risk as REITs Face Pressure
Healthcare Realty Trust is among seven high‑yield REITs flagged for possible dividend cuts, raising concerns for income‑focused investors. The company also set a date for its third‑quarter earnings call, giving analysts a chance to assess its financial health. These developments could influence how the market views HR’s dividend sustainability and earnings outlook.
HR Faces Dividend Cut Risk as REITs Face Pressure. Healthcare Realty Trust is among seven high‑yield REITs flagged for possible dividend cuts, raising concerns for income‑focused investors. The company also set a date for its third‑quarter earnings call, giving analysts a chance to assess its financial health. These developments could influence how the market views HR’s dividend sustainability and earnings outlook.